MaxCyte Inc. Reports Mixed Financial Results Amid Sector ChallengesMaxCyte Inc. faces financial challenges, including a widened loss and decreased revenue, but remains confident in its strategic direction and long-term prospects.MaxCyte Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 2025-05-08 3 minutes to read